11d
Zacks Investment Research on MSNVertex Up 25% YTD: Should You Buy, Sell or Hold the Stock?Vertex Pharmaceuticals Incorporated VRTX stock has plunged 25.3% this year so far against the industry’s 5.4% increase. VRTX ...
Vertex Pharmaceuticals (VRTX) announced several updates on the company’s type 1 diabetes portfolio. Vertex has completed enrollment and dosing ...
Morgan Stanley raised the firm’s price target on Vertex (VERX) to $60 from $57 and keeps an Overweight rating on the shares. The company’s ...
Hosted on MSN11mon
Vertex to Pay $4.9 Billion for Kidney Disease Drug DeveloperVertex will pay $65 a share in cash for Alpine ... The company is testing the treatment in a form of kidney disease, as well as other autoimmune diseases, including lupus and a blood disorder ...
Vertex AI Search for healthcare's new ... where nearly 90% of healthcare data is in image form – such as x-rays, scans, or photos. To give healthcare professionals a comprehensive understanding ...
an industry in which almost 90% of data is in image form, like x-rays or scans, according to research. With the new multimodal functionality Google is calling “Visual Q&A,” Vertex AI Search ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results